Mariner Independent Advisor Network’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Mariner Independent Advisor Network’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.49M	Buy	+1,252,822	New	+$1.35M	0.06%	305

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Mariner Independent Advisor Network's INFI Position: Q3 2022 in Review

Mariner Independent Advisor Network opened a new position in Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022: 1,252,822 shares worth $1.49M. The stake represents 0.06% of the portfolio and ranks #305 among its holdings.

76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

Mariner Independent Advisor Network held 1,252,822 shares of Infinity Pharmaceuticals, Inc. worth $1.49M as of Q3 2022.
Infinity Pharmaceuticals, Inc. was a new Mariner Independent Advisor Network position in Q3 2022.
Infinity Pharmaceuticals, Inc. made up 0.06% of Mariner Independent Advisor Network's portfolio in Q3 2022, its #305 holding.
76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on Mariner Independent Advisor Network's 13F filing for Q3 2022, filed 10 Nov 2022.